The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom
<br><strong>Purpose: </strong>The translation of genome sequencing into routine health care has been slow, partly because of concerns about affordability. The aspirational cost of sequencing a genome is $1000, but there is little evidence to support this estimate. We estimate the c...
Main Authors: | Schwarze, K, Buchanan, J, Fermont, JM, Dreau, H, Tilley, MW, Taylor, JM, Antoniou, P, Knight, SJL, Camps, C, Pentony, MM, Kvikstad, EM, Harris, S, Popitsch, N, Pagnamenta, AT, Schuh, A, Taylor, JC, Wordsworth, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Springer Nature
2019
|
Similar Items
-
Utility of whole-genome sequencing in the clinical diagnostic of rare inherited anaemias
by: C Camps, et al.
Published: (2018) -
Accurate costs of blood transfusion: a microcosting of administering blood products in the United Kingdom National Health Service
by: Stokes, E, et al.
Published: (2018) -
Clinically actionable mutation profiles in patients with cancer identified by whole-genome sequencing
by: Schuh, A, et al.
Published: (2018) -
Microcosting Analysis of Diffuse Large B-Cell Lymphoma Treatment in Malawi
by: Matthew S. Painschab, et al.
Published: (2019-07-01) -
Identification of circulating genomic and metabolic biomarkers in intrahepatic cholangiocarcinoma
by: Winter, H, et al.
Published: (2019)